San Diego, CA, United States of America

Srihari Cidambi Sampath

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srihari Cidambi Sampath. Retrieved from https://idiyas.com/inventor/srihari-cidambi-sampath

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Srihari Cidambi Sampath: Innovator in Therapeutic Proteins

Introduction

Srihari Cidambi Sampath is a notable inventor based in San Diego, CA. He has made significant contributions to the field of therapeutic proteins, particularly through his innovative work on fusogenic proteins.

Latest Patents

Srihari holds 1 patent related to his invention titled "Compositions, methods, and therapeutic uses related to fusogenic protein MINION." This invention provides novel compositions and methods that have potential therapeutic applications, focusing on the microprotein inducer of fusion.

Career Highlights

Srihari is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop groundbreaking therapeutic solutions.

Collaborations

Some of his notable coworkers include Srinath Cidambi Sampath and Stephane Corbel, who have collaborated with him on various projects.

Conclusion

Srihari Cidambi Sampath's contributions to the field of therapeutic proteins highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future developments in this important area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…